Latest receivables for HSAQ: $84K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), HSAQ shows a receivables of $84K. That compares with $89K in the prior-year period — down 5.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HSAQ's receivables is now $84K (was $89K) — a 5.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Health Sciences Acquisitions 2 is outperforming or lagging.
Tracking HSAQ's receivables over time shows whether Health Sciences Acquisitions 2 is scaling, shrinking, or reshaping that part of the business. The current reading is $84K That compares with $89K in the prior-year period — down 5.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Health Sciences Acquisitions 2's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $84K) with ownership activity and broader fundamentals.